RxDoctor Payments Data

Lauren Metterle, MD

Pediatric Dermatology · Clearwater, FLNPI 1033572391

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 39.1% of the total. Reporting peaked in 2022 at $564 and has fallen 50.8% since, to $277 in 2025.

$1,670in general payments, 2019–2025

Across 54 payments — averaging $30.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$652
  • Sun Pharmaceutical Industries Inc.$176
  • Pfizer$128
  • Kyowa Kirin, Inc.$119
  • Amgen$93
  • Sanofi$86
  • plus $415 from 10 others

What the payments were for

  • Food & beverage$1,670100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric dermatology providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$181,616
Medicare patients
471
Services billed
3,273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab27$101,016
Clobetasol Propionate83$3,007
Doxycycline Hyclate30$2,687
Fluorouracil23$1,485
Metronidazole25$1,116
Ketoconazole55$1,071
Triamcinolone Acetonide72$870
Halobetasol Propionate15$811
Mometasone Furoate41$766
Fluocinonide18$593
Ciclopirox13$516
Betamethasone Dipropionate12$476
Mupirocin44$304
ValacyclovirValacyclovir Hcl17$214
Terbinafine Hcl13$186

Paid to pharmacies, not to this prescriber.

Other pediatric dermatology in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →